Abbott Laboratories has stated that it will provide the recently approved arthritis medication, HumiraTM, free to Medicare patients who do not have perscription drug coverage until the government agrees to pay for the medicine. Humira is a TNF inhibitor and is approved for treatment in patients with rheumatoid arthritis. Patients should speak with their rheumatologist if they have any questions about the Humira Medicare Access Program.
Additionally, Abbott has established the Humira Reimbursement Resource Center for physicians and their staff to assist in determining patients’ eligibility and in securing appropriate coverage and/or reimbursement. Call 1-800-448-6472.
Receive the Latest News from Johns Hopkins Rheumatology
Join our mailing list to receive the latest news and updates from Johns Hopkins Rheumatology.